fda ruling glp 1 is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Navigating the -tides: Medication-Assisted Weight

It replenishes moisture and helps return that healthy, radiant glow

This was a retrospective cohort study of adult patients with a body mass index (BMI)30kg/m2 prescribed GLP-1 analogue therapy at an obesity specialist clinic in Vancouver, Canada

Trulicity vs Zepbound: Zepbound delivers 21% weight loss vs Trulicity's 4-7% with dual GIP/GLP-1 action

Learn how a smaller dose saves money and helps minimize side effects.

Book Robert Lustig to speak at your next event

Patients who reduced the frequency of GLP-1 dosing (from weekly to every other week) were able to maintain their weight loss and metabolic syndrome gains, as reported in this case series